Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy.
Anguille S, Lion E, Van den Bergh J, Van Acker HH, Willemen Y, Smits EL, Van Tendeloo VF, Berneman ZN. Anguille S, et al. Among authors: van tendeloo vf, van den bergh j, van acker hh. Hum Vaccin Immunother. 2013 Sep;9(9):1956-61. doi: 10.4161/hv.25373. Epub 2013 Jun 18. Hum Vaccin Immunother. 2013. PMID: 23778748 Free PMC article. Review.
Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.
Ogunjimi B, Smits E, Heynderickx S, Van den Bergh J, Bilcke J, Jansens H, Malfait R, Ramet J, Maecker HT, Cools N, Beutels P, Van Damme P. Ogunjimi B, et al. Among authors: van den bergh j, van damme p. Clin Vaccine Immunol. 2014 Mar;21(3):417-26. doi: 10.1128/CVI.00818-13. Epub 2014 Jan 15. Clin Vaccine Immunol. 2014. PMID: 24429070 Free PMC article.
HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells.
Van den Bergh JM, Guerti K, Willemen Y, Lion E, Cools N, Goossens H, Vorsters A, Van Tendeloo VF, Anguille S, Van Damme P, Smits EL. Van den Bergh JM, et al. Among authors: van tendeloo vf, van damme p. J Cell Mol Med. 2014 Jul;18(7):1372-80. doi: 10.1111/jcmm.12284. Epub 2014 Jun 30. J Cell Mol Med. 2014. PMID: 24979331 Free PMC article.
Interleukin-15: new kid on the block for antitumor combination therapy.
Van den Bergh JM, Van Tendeloo VF, Smits EL. Van den Bergh JM, et al. Among authors: van tendeloo vf. Cytokine Growth Factor Rev. 2015 Feb;26(1):15-24. doi: 10.1016/j.cytogfr.2014.09.001. Epub 2014 Sep 28. Cytokine Growth Factor Rev. 2015. PMID: 25306466
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.
Willemen Y, Van den Bergh JM, Lion E, Anguille S, Roelandts VA, Van Acker HH, Heynderickx SD, Stein BM, Peeters M, Figdor CG, Van Tendeloo VF, de Vries IJ, Adema GJ, Berneman ZN, Smits EL. Willemen Y, et al. Among authors: van tendeloo vf, van den bergh jm, van acker hh. Cancer Immunol Immunother. 2015 Jul;64(7):831-42. doi: 10.1007/s00262-015-1688-2. Epub 2015 Apr 12. Cancer Immunol Immunother. 2015. PMID: 25863943 Free PMC article.
The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells.
Willemen Y, Van den Bergh JM, Bonte SM, Anguille S, Heirman C, Stein BM, Goossens H, Kerre T, Thielemans K, Peeters M, Van Tendeloo VF, Smits EL, Berneman ZN. Willemen Y, et al. Among authors: van tendeloo vf, van den bergh jm. Oncotarget. 2016 Nov 8;7(45):73960-73970. doi: 10.18632/oncotarget.12170. Oncotarget. 2016. PMID: 27659531 Free PMC article.
413 results